2m 2m 2m 2m 2m 2m 2m
Neogenomics (NEO)
NASDAQ
$15.90+$0.61 (+4.01%)
Price as of Aug 03, 2026 2:17 PM EDT- $2.0BMarket Cap
- 196.32%1-Year Change
- Diagnostics & ResearchIndustry
Neogenomics (NEO)
$15.90+$0.61 (+4.01%)
NEO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.29 | ||
Change | -$0.59 (-3.72%) | ||
Open | $15.78 | ||
High | $15.90 | ||
Low | $15.27 | ||
Previous Close | $15.88 | ||
Volume | 3,035,355 | ||
30-Day Average Volume | 3,126,565 | ||
1-Week Change | 10.08% | ||
1-Month Change | 4.80% | ||
1-Year Change | 196.32% | ||
3-Year Change | -11.77% | ||
5-Year Change | -66.83% | ||
Fundamentals | |||
Shares Outstanding | 128.5M | ||
Total Assets | $1.4B | ||
Market Cap | $2.0B | ||
Enterprise Value | $2.2B | ||
Period: QTR TTM FY | |||
Revenue | $201.7M | ||
Net Income | $2.2M | ||
Free Cash Flow | $11.7M | ||
EBIT | $1.8M | ||
EBITDA | $9.5M | ||
Net Working Capital | $275.6M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | 232 | ||
Enterprise Value/Revenue | 11 | ||
P/B | 3 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | 167 | ||
Price/Operating Cash Flow | 98 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue